Meet the pioneer of cancer immunotherapies
Steven Rosenberg (left) is a Senior Investigator and Chief of the Surgery Branch at the National Cancer Institute (NCI; MD, USA). Rosenberg pioneered the development of effective immunotherapies for patients with advanced cancer, with his work contributing to IL-2, TIL and CAR-T therapies. Rosenberg recently won the 2024 AACR Award for Lifetime Achievement in Cancer Research, and we got the chance to sit down with him to talk about his fascinating career and the techniques that have shaped it. Here, he discusses his work researching and developing immunotherapies, what he’s currently focussed on, and the characteristics you need to thrive...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!
